Very interesting, significant pilot study given such a large group, more than 2450 patients with atopic dermatitis and wide age groups too. Looking forward to the TH, though it may not come till next week - IMO .
- Forums
- ASX - By Stock
- BOT
- What if...
What if..., page-29
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
-0.005(1.54%) |
Mkt cap ! $581.5M |
Open | High | Low | Value | Volume |
32.5¢ | 33.0¢ | 32.0¢ | $1.058M | 3.280M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 163870 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 632850 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 9386 | 0.340 |
1 | 6423 | 0.335 |
3 | 82480 | 0.330 |
3 | 104998 | 0.325 |
9 | 478435 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 24597 | 5 |
0.300 | 379333 | 3 |
0.305 | 75653 | 3 |
0.315 | 193614 | 3 |
0.320 | 55000 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online